Construct validity of the IDEOM MSK Questionnaire (IDEOM MSK-Q): an instrument to measure musculoskeletal symptoms in patients with psoriatic disease

By sjmartinez • January 27, 2025

Perez-Chada LM, Gondo G, Grant C, Woodbury M, Kucharik AH, Armstrong AW, Eder L, Mease P, Ogdie A, Strand V, Gottlieb AB, Merola JF. Construct validity of the IDEOM MSK Questionnaire (IDEOM MSK-Q): an instrument to measure musculoskeletal symptoms in patients with psoriatic disease. J Invest Dermatol. 2025 Jan 24:S0022-202X(25)00035-1. doi: 10.1016/j.jid.2024.10.619. Epub ahead of print. PMID: 39864735.

Tags: Dermatology, IDEOM, Musculoskeletal, outcome measure, psoriasis, psoriatic arthritis, Publications

Related Posts

Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial

Elbuluk N, Armstrong AW, Vender R, Bhutani T, Green L, Ferris LK, Laquer V, Moore A, Weisman J, Zhang W, Winkelman W, Gooderham MJ. Zasocitinib[...]

Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial

Lebwohl M, Blauvelt A, Kartman CE, Leatherwood C, Gordon KB, Sattar N, Puig L, Merola JF, Siu K, Wang R, Sun L, Leung A, Somani[...]

Use of ancillary studies in pediatric spitzoid neoplasms: A retrospective cohort study

Chen A, Krenitsky A, Perry SS, Tan KW, Swick BL, Anderson KR, Barry KK, Kelsey B, Carlberg VM, Coughlin CC, Craddock M, Fadzeyeva H, Ferringer[...]